LDS/Medical Tests/Beta-2 Glycoprotein 1 Antibody, IgA

Beta-2 Glycoprotein 1 Antibody, IgA

Beta-2 Glyocoprotein 1, now more often referred to as Apolipoprotein H (Apo-H), is an anticoagulant (anti-clotting) protein found in the blood. Beta-2 Glycoprotein is needed (in addition to cardiolipins) for anticoagulant (anti-clotting) activity. However, in addition to its clotting function, Beta-2 Glyocoprotein 1 serves as a major autoantigen for the production of antiphospholipid antibodies shown to be involved in autoimmune diseases, such as antiphospholipid syndrome (APS), some other coagulation disorders, and atherosclerosis. Low levels of Beta-2 Glycoprotein 1 Antibody are present at low concentration in normal individuals.

Many different disease states have increased levels of Beta-2 Glycoprotein 1 Antibody. Diseases include Antiphospholipid Syndrome (APS), thrombosis, pregnancy, thrombocytopenia, hemolytic anemia, rheumatic diseases, and systemic lupus erythematosus (SLE). Studies have suggested that only IgM Beta-2 Glycoprotein 1 Antibody is associated with a history of pregnancy loss. However, Beta-2 Glycoprotein 1 Antibodies are related to other obstetric complications such as pre-eclampsia and eclampsia. Beta-2 Glycoprotein 1 Antibody may be the sole antibody present in 10% of APS patients. In order to meet the criteria for APS, the beta-2 GP1 antibody must be present in significant amount. The titer may indicate the severity of APS in patients. It is made by liver cells, blood vessel lining cells (endothelial cells) and cells of the placenta (trophoblast cells). It is consists of 5 short chains of amino acids, one chain of which interacts with phospholipids of cell membranes.

  • Diagnosis of Antiphospholipid Syndrome
  • As an aid in diagnosis of thrombosis
  • Used to evaluate multiple pregnancy loss
  • As an aid in evaluation of pre-eclampsia and eclampsia
  • As an aid in evaluation of other bleeding disorders

Increased in:

  • Antiphospholipid syndrome
  • Thrombosis
  • Pregnancy
  • Thrombocytopenia
  • Hemolytic Anemia
  • Rheumatic disease
  • Systemic Lupus
  • Pregnancy loss
  • Pre-eclampsia and eclampsia

A high positive value for IgG and IgM Beta-2 GP1 antibody (>40 U/mL for IgG and/or IgM) are considered
diagnostic for APS.

A lower level, or IgA type antibody, are not diagnostic, but have been reported to occur in patients felt to have APS. To meet the laboratory diagnosis of APS, Anti-Beta-2 GP1 must be detected at least twice (two different sample dates) at least 12 weeks apart.

IgA anti-Beta 2 Glycoprotein 1 antibody >15 U/mL is not diagnostic of Antiphospholipid syndrome, even with negative anti-Beta 2 G1 IgG and IgM.

Antibody to Beta-2 G1 can be produced in increased amount following infection or in association with thrombosis. This test does not differentiate between this type of antibody and true autoantibody. This is why at least two abnormally high results are required at least twelve weeks apart.

Testing with different commercial assays (as in different laboratories) may yield quite different numerical results.

Anticoagulant therapy does not hinder detection of Beta-2 GP1 antibody.

15-30 mg/dL 150-300 mg/L

Some EIA tests report:
<10.0 U/mL (negative)
10.0 - 14.9 U/mL (borderline)
> or =15.0 U/mL (positive)

Enzyme-linked immunosorbent assay (ELISA)

Serum (SST) or Plasma Citrate (Blue Top)

  • Ambient - 5 days
  • Refrigerated - 14 days
  • Frozen - 30 days
ANA, RPR, PTT, Anti-cardiolipin Antibodies, Activated Partial Thromboplastin Time, Platelet Count, Prothrombin Time, Factor V Leiden, Factor II (Prothrombin) Gene mutation, Protein C, Protein S antigen and function, Cryofibrinogen, D-Dimer.
Same day after receipt in reference laboratory.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login